This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Fujita Academy, National Institute of Advanced Industrial Science and Technology. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tsukuba, JP (2020)
- Kyoto, JP (2022)
Company Filing History:
1 out of 8 
1 out of 1,765 
Years Active: 2020-2022
Title: Motohiro Nonaka: Innovator in Cytocidal Agents from Kyoto
Introduction
Motohiro Nonaka is a distinguished inventor based in Kyoto, Japan, known for his significant contributions to the field of biotechnology. With a focus on innovative solutions in medicinal chemistry, he has developed a unique cytocidal agent that showcases his dedication to advancing medical science.
Latest Patents
Nonaka holds a patent for a cytocidal agent that includes a peptide characterized by a specific amino acid sequence, as represented by SEQ ID NO: 1. The invention details a peptide that may consist of L-amino acids exclusively or may combine D-amino acids with L-amino acids in varied positions within the sequence. This innovative compound is designed to selectively bind to target molecules, offering potential applications in targeted cancer therapies and other therapeutic interventions.
Career Highlights
Motohiro Nonaka's career is marked by his tenure at Fujita Academy, where he has engaged in groundbreaking research. His expertise in peptide design and synthesis has positioned him as a leading figure in his field. His innovative approach and commitment to research excellence have made him a valuable asset to his organization.
Collaborations
Throughout his career, Nonaka has collaborated with esteemed colleagues, including Kazuhiro Sugihara and Naohiro Kanayama. These partnerships have fostered an environment of creativity and progress, enabling the advancement of research initiatives and the development of new therapeutic agents.
Conclusion
Motohiro Nonaka's contributions to the field of biotechnology, specifically through his patented cytocidal agent, reflect his innovative spirit and commitment to improving healthcare outcomes. His work at Fujita Academy, alongside his talented colleagues, continues to inspire advancements in medical research and therapy development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile